Breakthrough gene-editing treatment saves baby
KJ Muldoon was healed from a rare genetic condition


What happened
A team of doctors and scientists has used a tailor-made gene-editing therapy to treat an infant with a rare genetic condition, a medical first that opens the door to a new era of individualized medicine, especially for people with uncommon diseases, the researchers reported Thursday in The New England Journal of Medicine. "This is the future of medicine," said study coauthor Dr. Kiran Musunuru, a gene-editing expert at the University of Pennsylvania.
Who said what
KJ Muldoon was diagnosed with CPS1 deficiency, which causes toxic levels of ammonia in the blood, soon after his premature birth in Philadelphia last August. He had "perhaps as few as six months before a mounting risk of severe brain damage or death," The New York Times said. Instead, he "made medical history."
KJ's diagnosis launched an "all-out six-month sprint" by a network of researchers and companies to develop a therapy, "vet its safety and use it to fix an errant gene" in his liver, The Washington Post said. They used the gene-editing tool CRISPR to create an enzyme that "flips the mutated DNA 'letter'" to the "correct type" to process ammonia, The Associated Press said. KJ got his first injection in February, then lower doses in March and April.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
"We're still very much in the early stages of understanding what this medication may have done for KJ," said Dr. Rebecca Ahrens-Nicklas, his doctor at Children's Hospital of Philadelphia and a study coauthor. "But every day, he's showing us signs that he's growing and thriving." He is expected to go home in a few weeks.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'No one should be surprised by this cynical strategy'
Instant Opinion Opinion, comment and editorials of the day
-
Intellectual property: AI gains at creators' expense
Feature Two federal judges ruled that it is fair use for AI firms to use copyrighted media to train bots
-
Bill Moyers: the journalist who was the face of PBS
Feature A legend in public broadcasting
-
How mice with two dads bring us closer to two men having a child of their own
The Explainer Science breakthrough produces healthy, fertile mice from two sperm cells and an empty egg
-
Bacteria can turn plastic waste into a painkiller
Under the radar The process could be a solution to plastic pollution
-
Scientists want to regrow human limbs. Salamanders could lead the way.
Under the radar Humans may already have the genetic mechanism necessary
-
New York plans first nuclear plant in 36 years
Speed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Dehorning rhinos sharply cuts poaching, study finds
Speed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Is the world losing scientific innovation?
Today's big question New research seems to be less exciting
-
Sea lion proves animals can keep a beat
speed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammals
Speed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands